Journey Medical Corp. (DERM)
7.91
+0.16
(+2.06%)
USD |
NASDAQ |
Aug 24, 16:00
7.75
-0.16
(-2.02%)
Pre-Market: 08:26
Journey Medical Enterprise Value : 218.67M for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 218.67M |
| August 21, 2026 | 214.24M |
| August 20, 2026 | 207.05M |
| August 19, 2026 | 188.24M |
| August 18, 2026 | 184.09M |
| August 17, 2026 | 178.56M |
| August 14, 2026 | 185.75M |
| August 13, 2026 | 183.82M |
| August 12, 2026 | 177.73M |
| August 11, 2026 | 174.69M |
| August 10, 2026 | 178.01M |
| August 07, 2026 | 177.73M |
| August 06, 2026 | 180.50M |
| August 05, 2026 | 176.90M |
| August 04, 2026 | 176.90M |
| August 03, 2026 | 178.84M |
| July 31, 2026 | 176.07M |
| July 30, 2026 | 178.29M |
| July 29, 2026 | 169.99M |
| July 28, 2026 | 174.41M |
| July 27, 2026 | 176.07M |
| July 24, 2026 | 171.10M |
| July 23, 2026 | 181.88M |
| July 22, 2026 | 196.82M |
| July 21, 2026 | 202.07M |
| Date | Value |
|---|---|
| July 20, 2026 | 195.99M |
| July 17, 2026 | 197.92M |
| July 16, 2026 | 196.54M |
| July 15, 2026 | 200.97M |
| July 14, 2026 | 196.82M |
| July 13, 2026 | 189.63M |
| July 10, 2026 | 191.01M |
| July 09, 2026 | 193.50M |
| July 08, 2026 | 184.65M |
| July 07, 2026 | 186.45M |
| July 06, 2026 | 199.58M |
| July 02, 2026 | 195.99M |
| July 01, 2026 | 194.60M |
| June 30, 2026 | 195.71M |
| June 29, 2026 | 183.85M |
| June 26, 2026 | 179.20M |
| June 25, 2026 | 168.26M |
| June 24, 2026 | 185.49M |
| June 23, 2026 | 181.39M |
| June 22, 2026 | 174.00M |
| June 18, 2026 | 168.26M |
| June 17, 2026 | 160.06M |
| June 16, 2026 | 165.26M |
| June 15, 2026 | 171.54M |
| June 12, 2026 | 171.54M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Nektar Therapeutics | 1.967B |
| ANI Pharmaceuticals, Inc. | 1.938B |
| Corcept Therapeutics, Inc. | 13.00B |
| Veru, Inc. | 21.05M |
| Johnson & Johnson | 685.82B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.312M |
| Revenue (Quarterly) | 18.51M |
| Total Expenses (Quarterly) | 18.82M |
| EPS Diluted (Quarterly) | -0.0114 |
| Gross Profit Margin (Quarterly) | 61.58% |
| Profit Margin (Quarterly) | -1.69% |
| Earnings Yield | -2.93% |
| Normalized Earnings Yield | -2.929 |